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Amphiphilic 21-peptides with six and nine L-2-(2,2,2-trifluoroethyl)glycines as the hydrophobic amino acids and 
lysine and glutamic acid as the hydrophilic amino acids were synthesized. The CD spectra showed that these peptides with 
L-2-(2,2,2-trifluoroethyl)glycines took a random conformation in H20. On the contrary, similar amphiphilic 21-peptides
with leucine as the hydrophobic amino acids took a helical conformation in H20. The peptides with L-2-(2,2,2-triflµo­
roethyl)glycines took a helical conformation in H20 containing a > 20% volume of 2,2,2-trifluoroethanol. These facts
suggested the hydrophobic nature of the L-trifluoroethylglycines. The peptide with six L-2-(2,2,2-trifluoroethyl)glycines
took a helical structure in methanol, however it slowly changed into the fl-structure within 24 h. Interestingly, the peptide
with nine L-2-(2,2,2-trifluoroethyl)glycines formed a stable helix under the same conditions. The peptide with nine L-2-
(2,2,2-trifluoroethyl)glycines preferred a helical structure, probably because the assembling of the Tfeg side chains was
more effective in forming its helix rather than the fl-structure.
Recent progress on the de nova design and synthe­
sis of polypeptides has opened a new area in biomimetic 
chemistry. 1 Polypeptides with super secondary structures,
such as the assembled a-helices,2 artificial f:1-sheets,3 and
their three-dimensional complexes, have been successfully 
synthesized.1-7 Not only the synthesis of these complex
molecules, but recently, a protein-like function of the ar­
tificial peptides have been shown. For instance, some pep­
tides have been found to change their conformation from 
a-helices to the f:1-structure.4 The enzyme-like catalysis
of the peptides with the defined three-dimensional struc­
ture would be another recent example of the protein-like
function.5 Thus far, several concepts have been employed for
the polypeptide architecture; the hydrogen bonding between
the amide groups,30 the hydrophobic interaction between the
amphiphilic peptides,2ct Coulomb interaction of the amino
acid side chains,2b.2c,ze the metal chelation,6 the template-as­
sistance to define the polypeptide super-structure,7 and so
on.
If some new artificial factor can be introduced during the 
de nova synthesis with the brand-new interaction between the 
amino acids, the possibility of an "artificial super-structure", 
as described above, will be further expanded. With that in 
mind, multi-fluorinated amino acids should be highly hydro­
phobic,8-13 and therefore, the amphiphilic peptide with such 
multi-fluorinated amino acids is very interesting. Moreover, 
fluorinated compounds sometimes gather with each other, 
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suggesting a negative affinity of the fluorocarbons with the 
hydrocarbon groups.9d· 14 The fluoroalkyl groups in the fluori­
nated polypeptides have the possibility of an attractive inter­
action with each other. Interestingly, a novel hydrogen-bond­
like interaction with 0-H/FC has recently been reported. 15 
Though the fluorine atoms have often shown their unique 
effects in artificial biological molecules,8·9 few have studied
the character of polypeptides incorporating many multi-flu­
orinated amino acids.9d· 13 Herein, we wish to report on the
syntheses and their solution conformation of the 21-residue 
peptides with six and nine L�2-(2,2,2-trifluoroethyl)glycine 
(Tfeg, (S)-H2NCH(CH2CF3)C02 H) 10 residues (21 Tfeg6 and
21Tfeg9, Fig. 1). In their a-helix structure, hydrophobic 
Tfeg would occupy one face of the polypeptide helix surface 
and the hydrophilic lysine (Lys) and glutamic acid (Glu) 
residues occupy the other face. 16 We wish to show the effect
of the fluoroalkyl groups on the conformation of 21 Tfeg6 
and 21 Tfeg9, by a comparison with the amphiphilic peptides 
with leucine (Leu) residues instead of Tfeg (21Leu6 and 
21Leu9, Fig. 1).17 
Results and Discussion 
Design and Synthesis of Tfeg-Containing Peptide. For 
the helical peptide with a multi-fluorinated amino acid, L-2-
(2,2,2-trifluoroethyl)glycine (Tfeg) was chosen for several 
reasons. (1) Tfeg can be easily synthesized from 2,2,2-tri­
fluoroethanol (TFE), 10 in contrast to the lengthy synthesis
of, for instance, 5,5,5,5' ,5' ,5' -hexafluoroleucine.11• (2) Tfeg 
can be easily obtained in the L-form by a simple enzymatic 
resolution. 10 (3) The helical structure can be expected for
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21Tfeg6 (Xaa=Tfeg) and 21Leu6 (Xaa=Leu) 
side view 
upper view exaaQ Lys@ Ala 
21Tfeg9 (Xaa=Tfeg) and 21Leu9 (Xaa=Leu) 
side view 
21 
21 
upper view exaaOLys @Glu @Ala 
Tfeg: ,�Xe:: 
Fig. 1. Structure of H-(Ala-Tfeg-Ala-Lys-Ala-Tfeg­
Ala-)3-0H (21Tfeg6), H-(Ala-Leu-Ala-Lys-Ala-Leu­
Ala-)rOH (21Leu6), H- (Glu- Tfeg- Tfeg- Lys­
Ala-Tfeg-Ala-)3-0H (21Tfeg9), and H-(Glu-Leu-Leu­
Lys-Ala-Leu-Ala-)3-QH (21Leu9), in their a-helical con­
formation. 
the Tfeg-containing peptide as ethylglycine (2-aminobutyric 
acid) was reported to form an a-helix peptide. 18 4) Though 
the molecular weight (157 for Tfeg free amino acid) some­
what exceeds that of Leu ( 131 ), the covalent bond radius of 
H (0.30 A), F (0.58 A), and C (0.77 A)19 indicate that the 
molecular size may be between Ala and Leu. 
We had already synthesized the amphiphilic peptides 
21Leu6 (H-(-Ala-Leu-Ala-Lys-Ala-Leu-Ala-)3-0H)17" 
and 21Leu9 (H-(-Glu-Leu-Leu-Lys-Ala-Leu-Ala-)r 
OH),17b, I7c. 17<l in which the hydrophobic Leu occupies one 
face of the polypeptide helix surface and the hydrophilic Lys 
and Glu residues occupy the other in their a-helix structure. 
Such an amphiphilic nature of the helices can stabilize their 
a-helical structure. The former peptide 21Leu6 possesses
three Lys residues as the charged amino acid residue (side 
chain -NH3 +) in its hydrophilic surface. The latter peptide
21Leu9 possesses three Glu-Leu-Leu-Lys units, and the 
Coulomb interaction between the side chains of Glu and Lys, 
such as coo-·· -NH3 + (salt-bridging effect),2b,2c,2e might ex­
ist. Thus, we investigated the effect of fluorine atoms by 
substituting the hydrophobic Leu of 21Leu6 and 21Leu9 
with Tfeg. The structures of these novel peptides, 21 Tfeg6 
(H- (-Ala- Tfeg- Ala- Lys- Ala-Tfeg- Ala-)rOH) and 
21 Tfeg9 (H---(-Glu-Tfeg-Tfeg-Lys-Ala-Tfeg-Ala-)rOH), 
in their helical form are depicted in Fig. 1. In the helix struc­
ture, Tfeg covers 2/7 of the surface of 21 Tfeg6 and 3/7 of 
the surface of 21 Tfeg9. 
Amphiphilic Peptide with Fluoroalkyl Group 
For syntheses of Tfeg-containing peptides, a solution­
phase synthetic strategy was employed because an excess 
amount ofTfeg was necessary for the solid-phase synthesis.9<l 
In spite of the low basicity of the amino group of Tfeg 
(pKNH2 is 8.169 for Tfeg and 9.747 for Leu, pKcooH 
is 1.600 for Tfeg and 2.329 for Leu),20 the reaction in­
cluding Tfeg smoothly occurred throughout the synthe­
ses. By adopting the usual Boe strategy, the protected 7-
peptide Boc-Ala-Tfeg-Ala-Lys(ClZ)-Ala-Tfeg-Ala--OTce 
(3, -OTce is 2,2,2-trichloroethoxy) was synthesized via 
the coupling of Boe- Ala- Tfeg-Ala- OH and H- Lys­
(ClZ)-Ala- Tfeg-Ala-OTce by the EDC-HOBt method 
(Fig. 2, see Experimental Section for detail).2 1 Because some 
racemization or some side reaction occurred during coupling 
of the C-terminal multi-fluorinated amino acid residue,9•,9e, I Ie 
we chose the fragment coupling reactions at the positions of 
Ala and Lys(ClZ) as the C-termini. Actually, no racemiza­
tion of the Tfeg moiety was observed and the purity of the 
protected 7-peptide fragments was confirmed by HPLC and 
FAB-MS. Unfortunately, the 1 HNMR (500 MHz, 1D and 
2D-COSY) spectra were too complex for these peptide frag­
ments and also for the 21-peptides, because of the repeated 
sequential character of our peptides. 
As a temporary protection of the C-terminus, --OTce 
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Boe /c:CIZ OH H 
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Fig. 2. Syntheses of the protected heptapeptides (above) 
Boc-Ala-Tfeg-Ala-Lys(ClZ)-Ala-Tfeg-Ala-OR (OR = 
OTce (3), OBzl (4)) and (below) Boc-Glu(OcHex)-Tfeg­
Tfeg-Lys(CIZ)-Ala-Tfeg-Ala-OR (OR = OTce (7), OBzl 
(8)). (i) EDC-HOBt; (ii) HCl/dioxane; (iii) TFA; (iv) 
Zn-AcOH. 
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was chosen, which is selectively removable with 
Zn-AcOH.22 Solution-phase fragment coupling between 
Boc-Ala- Tfeg-Ala- Lys(ClZ)-Ala- Tfeg-Ala- OH and 
H-Ala-Tfeg-Ala-Lys(ClZ)-Ala-Tfeg-Ala-OBzl was per­
formed in CH2Clz-TFE (10 : 3, v/v), which is known to dis­
solve various protected peptides (Fig. 3).23 Because HPLC
and FAB-MS showed that the obtained 14-peptide was suf­
ficiently pure, this peptide was not thoroughly purified, but
again coupled at its N-terminal. A fully protected 21-peptide
(6) with six Tfeg residues was thus obtained. The protected
21-peptide with nine Tfeg residues (9) was similarly syn­
thesized. These protected 21-peptides (6 and 9) were then
treated with anhydrous hydrogen fluoride-10% anisole (v/v)
to deprotect the Boe-, -OBzl, -ClZ, and -OcHex groups.24 
The crude 21-peptides 21Tfeg6 and 21Tfeg9 were purified
by size-exclusion chromatography (Sephadex® G-25 eluting
with 40% AcOH), in which these peptides were eluted as a
single band. The elution volumes of 21 Tfeg6 and 21 Tfeg9
as well as those of 21Leu6 and 21Leu9 were similar. The
FAB-MS (both low MS and high resolution MS, see Exper­
imental Section) clearly indicated the molecular ion signals
for both peptides, 21Tfeg6 (2091, [M+Hj+) and 21Tfeg9
(2469, [M + Hj+). HPLC analyses for these peptide showed
that these peptide were obtained in high purity (see Experi­
mental Section).
Solution Conformation of Tfeg-Containing Peptides. 
In H20 (containing 3% HFIP), CD spectra indicated that the 
Tfeg-containing peptides 21 Tfeg6 and 21 Tfeg9 took the ran­
dom coil structure with [ O]min at 197 nm (Fig. 4, curves a and 
b); peptide concentration was 30 µM (1 M = 1 mol dm-3).25 
These facts were in contrast to the facts that the Leu-contain­
ing amphiphilic peptides, 21Leu6 and 21Leu9, showed typ­
ical CD spectra for the a-helices in the same solvents (Fig. 4, 
curves c and d) with [ BJ min at 222 and 208 nm and [ BJ max 
at 192 nm. 25•26 The values of [ Blmin at 222 nm were -35000 
deg cm2 dmo1- 1 for 21Leu6 and -29000 deg cm2 dmo1- 1 
for 21Leu9. The reasons why the Tfeg-containing peptides 
were of a distorted conformation in H20 are: (1) compared to 
Boc-(protected 7-peptide)-OTce (3, 7) ! Zn/ AcOH 
Boc-(protected 7-peptide )-OH 
Boc-(protected 7-pep\ide)-OBzl (4, 8) 
! TFA 
H-(protected 7-peptide)-OBzl 
I I I EDC/HOBt 
Boc-(protected 14-peptide)-OBzl 
! TFA 
Boc-(protected 7-peptide)-OH H-(protected 14-peptide)-OBzl 
! EDC/HOBt 
Boc-(protected 21-peptide)-OBzl (5, 9) 
l HF/ anisole 
21-peptide (21Tfeg6, 21Tfeg9) 
Fig. 3. Syntheses of the 21-peptides (21 Tfeg6 and 21 Tfeg9) 
via the stepwise fragment condensations. 
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Fig. 4. CD spectra of a) 21Tfeg6, b) 21Tfeg9, c) 21Leu6, 
and d) 21Leu9 in H20 (3% HFIP). [Peptide] = 30 µM. 
the side chain of Leu (isobutyl group), the side chain of Tfeg 
(-CH2CF3) might be too hydrophobic; therefore, the side 
chain of Tfeg preferred to aggregate randomly in H20 than 
to arrange to form a helical structure; (2) compared to the 
side chain of Leu, the side chain of Tfeg might be sterically 
too small to isolate the amide groups from the solvent H20; 
therefore, the solvent H20 could cleave the intramolecular 
hydrogen bonds. 
In TFE, not only the Leu-containing peptides, 21Leu6 and 
21Leu9, but also the Tfeg-containing peptides, 21 Tfeg6 and 
21Tfeg9, took the helical structure (Fig. 5) with [Blmin at 218 
and 205 nm. TFE is more hydrophobic than H20;27 therefore, 
the strong aggregation of Tfeg residues (the hydrophobic 
interaction between -CH2CF3 groups) may be weakened, 
60000 
'7 40000 a) 21Tfeg 6
0 b) 2ITfeg9E 
N 
c) 21Leu6E 20000 
bl) 
d) 21Leu9
0 -0 a) ·.i 
...
\� 
� -20000 �� 
� 
\ .. _ ... ··>��) 
-40000 ,_. /c) 
200 220 240 
Wavelength/ nm 
Fig. 5. CD spectra of a) 21Tfeg6, b) 21Tfeg9, c) 21Leu6, 
and d) 21Leu9 in TFE (3% HFIP). [Peptide] = 30 µM. 
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resulting in the helix formation of 21Tfeg6 and 21Tfeg9. 
The fact that hydrophobic TFE was necessary for the helix 
formation of 21 Tfeg6 and 21 Tfeg9 might suggest that Tfeg 
might be more hydrophobic than Leu. 
As we have reported earlier, 21Leu6 and 21Leu9 assem­
bled with each other to form the helix bundle structure, in 
which the Leu residues gathered inside via the hydrophobic 
interaction.17 The ratio of [ Blea. 220/[ Blea. 20s in the CD spec­
tra, which is a marker of the compactness of the helices,28 
decreased in TFE (21Leu6; 0.86 in H20 and 0.65 in TFE, 
21Leu9; 0.91 in H20 and 0.64 in TFE). The a-helicities 
([Blea. 220) also decreased in TFE.26 These facts suggested 
that the bundle structure of 21Leu6 and 21Leu9 collapsed 
into monomeric helices in hydrophobic TFE. This fact may 
imply that the helices of 21 Tfeg6 and 21 Tfeg9 in TFE also 
exist as the solvated form, not as the assembled helix form. 
A CD investigation of 21 Tfeg6 in various contents of TFE 
in H20 further demonstrated that TFE stabilized the helical 
structure (Fig. 6, filled circle). Below a TFE content of 20% 
(v/v), 21 Tfeg6 showed the CD spectrum of the random coil 
peptide with [ Bl min at 197 nm as described above. Above a 
20% content ofTFE, 21 Tfeg6 showed a helical CD spectrum 
with [Olmin at 205 and 218 nm (data not shown, but almost 
similar to that in TFE (Fig. 5, curve a)). TFE may probably 
solvate the Tfeg side chains; therefore, the helical structure 
of 21Tfeg6 may be stabilized. Interestingly, the a-helicity 
evaluated with [ 8ht8 was similar for the 20% TFE and 97% 
TFE. This fact might suggest that the 20% TFE amount was 
sufficient to solvate 21 Tfeg6. In contrast, the helical struc­
ture of21Tfeg6 was hardly stabilized by MeOH. The [8ht8 
values of the CD spectra of 21 Tfeg6 in various MeOH con­
tents in H20 are shown in Fig. 6 (open circle, measured just 
after preparing the sample). In contrast to the circumstance in 
TFE-H20, the helicity of 21Tfeg6 only gradually increased 
([Ohts decreased) with an increase in MeOH. Interestingly, 
0 a 
a u 
00 " .,,, 
-5000-+---�--�---'-----'-----+ 
-10000 
-15000 
-20000 
0 20 40 60 80 100 
TFE or MeOH content in HiO (v/v) I % 
Fig. 6. TFE (e) and MeOH (0)-induced helix structure for 
21Tfeg6 evaluated by the [Ohis value in the CD spectra. 
[21 Tfeg6] = 30 µM. 
Amphiphilic Peptide with Fluoroalkyl Group 
the [8ht8 in 97% MeOH was similar to that in 20-97% 
TFE. These facts suggest that the hydrophobic interaction of 
MeOH with 21Tfeg6 was not sufficient below 97% MeOH 
to stabilize its helical structure. This might suggest that the 
interaction ofTFE with Tfeg may be effective in forming the 
helix structure. 
Interestingly, the helical structure of 21 Tfeg6 in MeOH 
was not stable with time. In Fig. 7, the CD spectra of21Tfeg6 
in MeOH is shown 5 min, 12 h, and 24 h after dissolving 
the peptide. Clearly the helical structure of 21 Tfeg6 ([ Blmin 
was 205 and 218 nm) in MeOH gradually changed into the 
/3-structure ([Olmin was 215 nm).25 However, the helical 
structure of not only 21Leu6 and 21Leu9 but also 21 Tfeg9 
were stable under the same conditions. In the /3-structure, 
the side chains of the neighboring amino acids are located 
apart. Therefore, if 21 Tfeg9 took the /3-structure, the neigh­
boring Tfeg residues in its -Glu-Tfeg-Tfeg-Lys- sequence 
would be separated from each other. One of the reasons why 
21Tfeg9 preferred the helical structure and 21Tfeg6 tended 
to form /3-structure in MeOH, may be because the Tfeg 
residues in the -Glu-Tfeg-Tfeg-Lys- sequence in 21 Tfeg9 
could be closely located in the helical structure, but separated 
in its /3-structures. On the other hand, the Tfeg residues of 
21 Tfeg6 were not in the close proximity both in the he­
lical and in the /3-structure. The second possible reason 
why 21 Tfeg9 preferred the helical structure in MeOH is the 
Coulomb interaction between the Glu and Lys side chains of 
21 Tfeg9. The salt bridge between these residue may stabilize 
its helical structure. Thus, the unstable helical structure of 
21Tfeg6 in MeOH slowly transformed into the /3-structure.4 
The fact that the 21 Tfeg9 formed a stable helix in MeOH, 
while 21 Tfeg6 formed an unstable helix, also suggested that 
the Tfeg side chains tend to attract each other. 
As a conclusion, the amphiphilic peptide with Tfeg 
residues 21 Tfeg6 and 21 Tfeg9 had a random structure in 
0 a 
u 
00 " .,,, 
a) in TFE 
20000 
b) in MeOH (after 0.5 h) 
c) in MeOH (after 12 h)
d) in MeOH (after 24 h) 
0 
-20000 
-40000 -'---r----r---r--"-T""---.----+ 
200 210 220 230 240 250 
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Fig. 7. CD spectra of 21Tfeg6 in a) TFE, b) MeOH (after 
5 min), c) MeOH (after 12 h), d) MeOH (after 24 h). 
[21 Tfeg6] = 30 µM. 
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H20, though 21Leu6 and 21Leu9 had a helical structure 
under the same conditions. In a > 20% TFE content 
in H20, 21 Tfeg6 and 21 Tfeg9 showed a helical structure. 
These Tfeg-containing peptides were partially helical in 
MeOH-H20, however, the large content of MeOH was nec­
essary to stabilize the helical structure in this case. The heli­
cal 21 Tfeg6 in MeOH slowly changed into the fl-structure, 
however, the helical 21 Tfeg9 in MeOH did not change its 
structure under the same conditions. The peptide with suc­
cessive Tfeg residues 21 Tfeg9 (-Glu-Tfeg-Tfeg-Lys- se­
quence) did not tend to transform into the fl-structure, which 
may be because the assembling of the Tfeg side chains may 
be more effective in forming its helical structure rather than 
the fl-structure. Because the side chains of Tfeg residue may 
tend to gather with each other, this nature might be beneficial 
for the design of a sophisticated three-dimensional structure 
of artificial peptides. 
Experimental 
Analytical Methods. An HPLC analysis was carried out using 
a Hitachi L-7100 intelligent pump equipped with a Hitachi L-4200 
UV-vis detector and a Hitachi D-7500 chromato-integrator. The 
analysis was performed on a Wakosil® 5C4 column ( 4.6 x 150 mm) 
eluting with a linear gradient of a) CH3CN/H20/TFA = 37 /63/0.1 to 
100/0/0.1 (v/v/v) or b) CH3CN/H20fTFA = 0/100/0.1 to 100/0/0.1 
(v/v/v) over 30 min at flow rate of 1.0 ml min-1 with detection
at 220 nm. Size exclusion chromatography was performed with a 
Sephadex® G-25 column (2.0x76 cm) eluting with 40% AcOH. 
FAB-MS spectra were obtained with a JEOL DX-300 or SX-102 
mass spectrometer. High-resolution MS spectra (HIMS) were cali­
brated with Csl. The CD spectra were recorded on a JASCO J-500 
or J-720 spectropolarimeter using a quartz cell of 1 mm pathlength 
at 25 °C using a 30 µM peptide concentration. All CD samples 
contained 3% (v/v) HFIP. All CD samples were measured just after 
preparing each sample, unless otherwise noted. The Cotton effect 
was evaluated by the molar ellipticity [ 8] per residue. 
Materials. 2-(2,2,2-Trifluoroethyl)glycine (Tfeg) was syn-
thesized and enzymatically resolved into its L-form according to 
the literature. 10 The amino acid derivatives and the reagents for the
peptide synthesis were purchased from Peptide Institute Inc. and 
Watanabe Chemical Industries, Ltd. Other reagents . and solvents 
were purchased from Wako Pure Chemical Industries, Ltd. 
Boc-Ala-Tfeg-Ala-OTce (1). The dicyclohexylarnine salt 
of Boc-Tfeg-OH (1.8 g, 4.0 mmol) and HCl·H-Ala-OTce (1.2 
g, 4.5 mmol, synthesized from Boe-Ala-OH and 2,2,2-trichlo­
roethanol with EDC/4-dimethylarninopyridine method,22 then Boe
protection was removed with HC1/dioxane)29 were suspended in 30 
ml of DMF, then EDC·HCl (1.2 g, 6.0 mmol), HOBt•H20 (0.77 g, 
5.0 mmol), and EtJN (0.63 ml, 4.5 mmol) were added at O °C.21
The mixture was stirred at room temperature overnight and then 
evaporated. The remained oil was dissolved in ethyl acetate and 
the organic layer was successively washed with aqueous NaHC03 
and aqueous citric acid. After evaporation, Boc-Tfeg-Ala-OTce 
was almost quantitatively obtained, which was pure enough for 
further synthesis. The successive coupling of Boe-Ala-OH with 
HCl • H-Tfeg-Ala-OTce (generated from Boc-Tfeg-Ala-OTce and 
HCl/dioxane) was similarly performed. After a work up, 1 was 
solidified by adding ethyl ether/petroleum ether (yield 1.8 g, 3.4 
mmol, 85%). FAB-MS (3-nitrobenzyl alcohol), 530 ([M+Ht), 
552 ([M+Nat). 
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Boc-Lys(CIZ)-Ala-Tfeg-Ala-OTce (2). The cou-
pling of Boe- Lys(ClZ)- OH (0.33 g, 0.80 mmol) with 
HCl·H-Ala-Tfeg-Ala-OTce (0.36 g, 0.77 mmol, generated from 
1 and HCl/dioxane) was similarly performed and the crude product 
was chromatographed over silica gel (CHCIJ-3% MeOH) giving 2
as an oil (0.50 g, 0.60 mmol, 78% yield). FAB-MS (3-nitrobenzyl 
alcohol), 828 ([M + Ht), 850 ([M + Nat). 
Boc-Ala-Tfeg-Ala-Lys(CIZ)-Ala-Tfeg-Ala-OTce (3). To 
the AcOH (12 ml) solution of 1 (0.32 g, 0.60 mmol), 2.3 g of 
Zn powder was added and the mixture was stirred for 5 h. After 
filtration, the solvent was evaporated and then washed with aqueous 
citric acid to give 0.25 g (0.60 mmol) of Boc-Ala-Tfeg-Ala-OH 
as an oil. This oil was dissolved in 10 ml of DMF; then, TFA·Lys­
(ClZ)-Ala-Tfeg-Ala-OTce (0.47 g, 0.56 mmol, generated from 2 
and TFA), DIEA (0.10 ml, 0.60 mmol), HOBt•H20 (0.11 g, 0.70 
mmol), andEDC·HCl (0.15 g, 0.80 mmol) wereadded at 0 °C. The 
mixture was stirred at O °C for 24 h and then evaporated. After 
work-up, 3 was obtained in 93% yield (0.58 g, 0.52 mmol), which 
was pure enough for further synthesis. HPLC (gradient a), 20. 7 min. 
FAB-MS (2,2' -dithiodiethanol), 1110 ([M + Ht), 1132 ([M + Nat). 
Boc-Ala-Tfeg-Ala-Lys(CIZ)-Ala-Tfeg-Ala-OBzl (4). 
Starting from HCl·H-Ala-OBzl, 4 was synthesized in a manner 
similar to 3. HPLC, 19.9 min. FAB-MS (2,2'-dithiodiethanol), 
1067 ([M+Ht), 1089 ([M+Nat). 
Boc-(-Ala-Tfeg-Ala-Lys(CIZ)-Ala-Tfeg-Ala-)3-0Bzl (5). 
The HFIP (0,20 ml) solution of 3 (0.13 g, 0.12 mmol) was di­
luted with 2.0 ml of AcOH, then Zn powder (0.13 g) was added 
and the mixture was stirred for 3 h. After filtration, the mixture 
was concentrated and solidified with the addition of aqueous cit­
ric acid. Boc-Ala-Tfeg-Ala-Lys(ClZ)-Ala-Tfeg-Ala-OH was 
thus obtained as a solid (0.12 g, 0.12 mmol), which was pure 
enough for further synthesis. This solid was dissolved by adding 
CH2Clz (10 ml) and TFE (3 ml), 23 then TFA • H-Ala-Tfeg-Ala-Lys­
(ClZ)-Ala-Tfeg-Ala-OBzl (0.11 g, 0.10 mmol, generated from 4 
and TFA), DIEA (17 µl, 0.10 mmol), HOBt·H20 (18 mg, 0.12 
mmol), and EDC·HCl (29 mg, 0.15 mmol) were added at O °C. 
The mixture was stirred at O °C for 36 h. After a work-up, 0.20 g 
(0.10 mmol) of the protected 14-peptide Boc-{-Ala-Tfeg-Ala-Lys­
(ClZ)-Ala-Tfeg-Ala-)z-OBzl was obtained, which was pure 
enough for further synthesis. HPLC (gradient a), 24.8 min. 
FAB-MS (3-nitrobenzyl alcohol), 1948 ([M+Nat). Similarly, 
Boc-Ala-Tfeg-Ala- Lys(ClZ)-Ala-Tfeg-Ala-OH (76 mg, 78 
µmol) was again coupled with TFA · H-(-Ala-Tfeg-Ala- Lys­
(ClZ)-Ala-Tfeg-Ala-)z-OBzl (0.12 g, 60 µmol, generated from 
the above 14-peptide and TFA) in CH2Ch (12 ml)-TFE (5 ml) 
using DIEA (14 µl, 78 µmol), HOBt·H20 (14 mg, 90 µmol), 
and EDC·HCl (19 mg, 0.10 mmol). After a work-up, the pro­
tected 21-peptide (5) was solidified with the addition of aqueous 
NaHC03, yielding 0.17 g (60 µmol). This material was also pure 
enough for further synthesis. FAB-MS (3-nitrobenzyl alcohol), 
2807 ([M + Nat). 
H-(-Ala-Tfeg-Ala-Lys-Ala-Tfeg-Ala-)rOH (21 Tfeg6). 
The protected 21-peptide 5 (88 mg, 32 µmol) was treated with anhy­
drous HF (9.0 ml)-anisole (1.0 ml) atO °C for 1 h.24 Thefully depro­
tected peptide was washed, lyophilized, and then purified by size 
exclusion chromatography (Sephadex® G-25) eluting with 40% 
AcOH. The peptide eluted as a single band. The appropriate frac­
tions were collected, yielding 20 mg (9.6 µmol) of 21Tfeg6. FAB­
MS (2,2' -dithiodiethanol), 2090 ([M + Ht). HIMS, Found: m/z
2089.8920. Calcd for C78H123N24022F1s: M, 2089.8955. HPLC 
(gradient b), 16.4 min. 
Boc-Glu(OcHex}-Tfeg-Tfeg-Lys(CIZ)-OTce (6). The di-
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cyclohexylamine salt of Boc-Tfeg-OH (0.87 g, 2.0 mmol) and 
HCl·H-Lys(ClZ)-OTce (1.1 g, 2.2 mmol) were suspended in 10 
ml of DMF, then EDC·HCl (0.58 g, 3.0 mmol), HOBt·H20 (0.37 
g, 2.4 mmol), and Et3N (0.30 ml, 2.2 mmol) were added at 0 
�C. The mixture was stirred at room temperature overnight and 
then evaporated. After a work-up, almost pure Boc-Tfeg-Lys­
(ClZ)--OTce was quantitatively obtained. Next, a similar cou­
pling of Boc-Tfeg-OH with HCl·H-Tfeg-Lys(ClZ)-OTce gave 
Boc-Tfeg-Tfeg-Lys(ClZ)--OTce in 65% yield. The successive 
coupling of Boc-Glu(OcHex)-OH with HCl·H-Tfeg-Tfeg-Lys­
(ClZ)--OTce gave 6 in 96% yield. FAB-MS (3-nitrobenzyl alcohol), 
1037 ([M + Ht). 
Boc-Glu(OcHex)--Tfeg-Tfeg-Lys(CIZ)--Ala-Tfeg-Ala­
OTce (7). The treatment of 6 (0.42 g, 0.40 mmol) in 8.0 ml 
of AcOH with Zn (1.6 g) gave Boc-Glu(OcHex)-Tfeg-Tfeg-Lys­
(ClZ)--OH quantitatively. The coupling of this tetrapeptide (0.40 
mmol) with HCl·H-Ala-Tfeg-Ala-OTce (0.16 g, 0.34 mmol) was 
performed in 4.0 ml of DMF with DIEA (66 µl, 0.40 mmol), 
HOBt· H20 (92 mg, 0.60 mmol), and EDC· HCl (0.11 g, 0.60 mmol) 
at O °C for 24 h. After work-up, 7 was obtained as an oil (0.41 g, 
0.31 mmol, 91%). HPLC (gradient a), 25.1 min. FAB-MS (2,2'­
dithiodiethanol), 1318 ([M+Ht). 
Boc-Glu(OcHex)-Tfeg-Tfeg-Lys(CIZ)--Ala-Tfeg-Ala­
OBzl (8). The coupling of Boc-Glu(OcHex)--Tfeg-Tfeg-Lys­
(ClZ)--OH with HCl·H-Ala-Tfeg-Ala-OBzl was similarly per­
formed to give 8. HPLC (gradient a), 24.5 min. FAB-MS (2,2' -
dithiodiethanol), 1291 ([M + Ht). 
Boc-(-Glu(OcHex)-Tfeg-Tfeg-Lys(CIZ)--Ala-Tfeg­
Ala-h-0Bzl" (9). To the TFE (0.50 ml)--CH2Ch (l.O ml) solu­
tion of Boc-Glu(OcHex)--Tfeg-Tfeg-Lys(ClZ)--Ala-Tfeg-Ala-OH 
(generated from 7 (30 mg, 25 µmol) and Zn/AcOH), TFA•H-Glu­
(OcHex)--Tfeg-Tfeg-Lys(ClZ)--Ala-Tfeg-Ala-OBzl (generated 
from 8 (32 mg, 25 µmol) and TFA), DIEA (4.0 µl, 20 
µmol), HOBt·H20 (5.0 mg, 30 µmol), and EDC·HCl (7.0 
mg, 37 µmol) were added and the mixture was stirred at 0 
° C for 48 h. After a work- up, the protected 14-peptide 
Boc-{-Glu(OcHex)-Tfeg-Tfeg-Lys(ClZ)-Ala-Tfeg-Ala-)z-OBzl 
(39 mg, 17 µmol) was obtained. This material was pure 
enough for further synthesis. HPLC, 29.8 min. FAB-
MS (3- nitrobenzyl alcohol), 2368 ([M + Nat). Next, 
Boc-Ala-Tfeg-Ala-Lys(ClZ)-Ala-Tfeg-Ala-OH (15 mg, 13 
µmol) was coupled with TFA · H-(-Glu(OcHex)-Tfeg-Tfeg-Lys­
(ClZ)-Ala-Tfeg-Ala-)2--0Bzl (23 mg, 10 µmol) in TFE-CH2Ch, 
giving 32 mg (9.4 µmol) of the protected 21-peptide (9). This mate­
rial was pure enough for further synthesis. FAB-MS (3-nitrobenzyl 
alcohol), 3434 ([M+Nat). 
H-(-Glu-Tfeg-Tfeg-Lys-Ala-Tfeg-Ala-)3-0H (21 Tfeg9). 
The protected 21-peptide 9 (41 mg, 12 µmol) was treated with 
HF (9.0 ml)-anisole (1.0 ml) at O °C for 1 h. The fully deprotected 
peptide was washed, lyophilized, and then purified by size exclu­
sion chromatography (Sephadex® G-25) eluted with 40% AcOH. 
The peptide eluted as a single band. The appropriate fractions were 
collected, yielding 14 mg (5.7 µmol) of 21Tfeg9. FAB-MS (2,2'­
dithiodiethanol), 2469 ([M+Ht), HIMS. Found: m/z 2467.8781. 
Calcd for Cs1H126N2402sF21: M, 2467.8741. HPLC (gradient b), 
17.6 min. 
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